Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04111757 · ClinicalTrials.gov registry record · NA
A Study With Technolas® TENEO 317 Model 2 Excimer Laser to Treat Participants With Myopia or Myopic Astigmatism
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT04111757 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 168 participants.
The verdict
NCT04111757, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
The primary objective of this study is to collect safety and effectiveness data for the Technolas Teneo 317 Model 2 excimer laser for LASIK correction in participants with myopia and myopic astigmatism.
Interventions
- DEVICE Technolas® TENEO 317 Model 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2019-07-25 |
| Est. Completion | 2021-08-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04111757
The ClinicalTrials.gov registry entry for NCT04111757 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Technolas® TENEO 317 Model 2 is the first listed.
NCT04111757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04111757 about?
NCT04111757 is a clinical study titled "A Study With Technolas® TENEO 317 Model 2 Excimer Laser to Treat Participants With Myopia or Myopic Astigmatism". The primary objective of this study is to collect safety and effectiveness data for the Technolas Teneo 317 Model 2 excimer laser for LASIK correction in participants with myopia and myopic astigmatism.
What is the current status of trial NCT04111757?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2019-07-25. Estimated completion is 2021-08-06.
What interventions are being tested in trial NCT04111757?
The interventions under investigation include: Technolas® TENEO 317 Model 2 (DEVICE).
Who is sponsoring clinical trial NCT04111757?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.